Bernd Benninghoff
Overview
Explore the profile of Bernd Benninghoff including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
28
Citations
367
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Navarro-Torne A, Anderson A, Panwar K, Ghys E, Benninghoff B, Weynants V, et al.
Vaccine
. 2025 Jan;
47:126701.
PMID: 39798435
No abstract available.
2.
Standaert B, Raes M, Ethgen O, Benninghoff B, Toumi M
Vaccines (Basel)
. 2024 Nov;
12(11).
PMID: 39591168
New vaccination programs measure economic success through cost-effectiveness analysis (CEA) based on an outcome evaluated over a certain time frame. The reimbursement price of the newly approved vaccine is then...
3.
Navarro-Torne A, Anderson A, Panwar K, Ghys E, Benninghoff B, Weynants V, et al.
Vaccine
. 2024 Aug;
42(24):126215.
PMID: 39213982
Background: Bivalent human papillomavirus HPV16/18-AS04 vaccine (Cervarix, GSK) offers direct protection against HPV16/18. Results from randomised controlled trials showed cross protective effects and suggested that declines in some closely related...
4.
Cohen R, Martinon-Torres F, Posiuniene I, Benninghoff B, Oh K, Poelaert D
Infect Dis Ther
. 2022 Dec;
12(1):31-32.
PMID: 36495406
No abstract available.
5.
Cohen R, Martinon-Torres F, Posiuniene I, Benninghoff B, Oh K, Poelaert D
Infect Dis Ther
. 2022 Nov;
12(1):9-29.
PMID: 36355309
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has pushed many healthcare systems into crisis. High vaccine coverage amongst children reduces emergency room presentations, hospital admissions and deaths due...
6.
Defining the Recipe for an Optimal Rotavirus Vaccine Introduction in a High-Income Country in Europe
Standaert B, Benninghoff B
Viruses
. 2022 Feb;
14(2).
PMID: 35216018
Observational data over 15 years of rotavirus vaccine introduction in Belgium have indicated that rotavirus hospitalisations in children aged <5 years plateaued at a higher level than expected, and was...
7.
Standaert B, Strens D, Raes M, Benninghoff B
Vaccine
. 2022 Feb;
40(13):1948-1957.
PMID: 35190208
Background: Observational data on the reduction in hospitalisations after rotavirus vaccine introduction in Belgium suggest that vaccine impact plateaued at an unexpectedly high residual hospitalisation rate. The objective of this...
8.
Vetter V, Gardner R, Debrus S, Benninghoff B, Pereira P
Hum Vaccin Immunother
. 2021 Feb;
18(1):1870395.
PMID: 33605839
Robust scientific evidence related to two rotavirus (RV) vaccines available worldwide demonstrates their significant impact on RV disease burden. Improving RV vaccination coverage may result in better RV disease control....
9.
Buchy P, Chen J, Zhang X, Benninghoff B, Lee C, Bibera G
Expert Rev Vaccines
. 2020 Dec;
20(12):1499-1514.
PMID: 33275065
Introduction: Rotavirus infection causes a significant proportion of diarrhea disease burden in children <5 years of age in Asia and the Pacific regions. The World Health Organization recommends that rotavirus...
10.
Standaert B, Strens D, Pereira P, Benninghoff B, Raes M
Infect Dis Ther
. 2020 Oct;
9(4):967-980.
PMID: 33025558
Introduction: The rotavirus (RV) vaccine Belgium Impact Study (RotaBIS) evaluated the vaccine effect on RV-related hospital care in children up to 5 years old over a period of 13 years....